Rubius Therapeutics(RUBY)

0.0570 0.0000 0.0%

今开:0.0昨收:0.057
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:5152671.0

Rubius Therapeutics的最新讨论

Replix锐璞美股2020-12-15 00:12

$Rubius Therapeutics(RUBY)$ 这是我们刚覆盖不久的细胞疗法的公司,没想到已经翻倍了,[大笑][大笑]网页链接$Arvinas(ARVN)$ $Beam Therapeutics(BEAM)$查看全文

薛定锷之猫2020-08-11 09:17

$Rubius Therapeutics(RUBY)$ Flagship VC主控38m, Capital World和Research各占1.8+1.5m, BG 4.3m, ARCH 2.6m查看全文

chuminhua2020-03-16 15:37

3/12,Rubius Therapeutics$Rubius Therapeutics(RUBY)$ 在2019年报中披露,主要在研药物RTX-134治疗苯丙酮尿症(PKU)的Ib期研究数据“无法解释”,因此停止了临床研究,并将公司资源集中在肿瘤和自身免疫疾病药物上。查看全文

美股滚雪球2020-02-18 16:42

老朋友是否给出新机会,查看内容更新$Rubius Therapeutics(RUBY)$ $Scynexis(SCYX)$ $Millendo疗法(MLND)$查看全文

Leonfz2018-09-22 20:27

$Rubius Therapeutics, Inc.(RUBY)$ 如约而至的上涨[大笑]查看全文

牛唐2018-07-28 22:32

$Rubius Therapeutics(RUBY)$ 是在Flagship VentureLabs孵化的突破性治疗平台,研发管线是建立在其独创的红细胞治疗技术Red-Cell Therapeutics(RCTs)。
RCT技术可将供体的造血干细胞改造成特殊的"治疗性"红细胞,并在体外大规模培养,像"输血"一样将药物回输到患者体内,整...查看全文

1 2 3

Rubius Therapeutics的公告

股东委托书协议

$Rubius Therapeutics(RUBY)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-23-030329  Act: 34  Size: 2 MB 网页链接

当期报告

$Rubius Therapeutics(RUBY)$ 8-K Current report, items 3.01 and 5.02 Accession Number: 0001104659-23-028428  Act: 34  Size: 204 KB 网页链接

超过5%股东持股披露「修订」

$Rubius Therapeutics(RUBY)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001088875-23-000072  Act: 34  Size: 10 KB 网页链接

其他

$Rubius Therapeutics(RUBY)$ PRER14A Preliminary Proxy Soliciting materials Accession Number: 0001104659-23-027696  Act: 34  Size: 2 MB 网页链接

持股变动声明

$Rubius Therapeutics(RUBY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-026139  Size: 5 KB 网页链接

其他

$Rubius Therapeutics(RUBY)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-23-025672  Act: 34  Size: 508 KB 网页链接

年度财报

$Rubius Therapeutics(RUBY)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001709401-23-000005  Act: 34  Size: 7 MB 网页链接

其他

$Rubius Therapeutics(RUBY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-025604  Act: 33  Size: 28 KB 网页链接

其他

$Rubius Therapeutics(RUBY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-025605  Act: 33  Size: 28 KB 网页链接

其他

$Rubius Therapeutics(RUBY)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-025606  Act: 33  Size: 28 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25